Pneumonia News

Vaccination with the 13-valent pneumococcal conjugate vaccine has consistently decreased the rate of community-acquired pneumonia among French children since its implementation in 2010, according to an analysis based on a prospective multicenter study published in JAMA Pediatrics.

The 10 leading causes of death in the United States in 2017 were the same as 2016, with heart disease and cancer topping the list, according to a National Center for Health Statistics Data Brief published by the CDC.

Researchers at Emory University who initiated an intervention including pre- and day-of-visit planning, weekly reviews and monthly feedback increased combination pneumococcal vaccination rates among patients with systemic lupus erythematosus from 10% to 59%, according to findings published in the Journal of Rheumatology.

Pneumonia can be ruled out for most children with a suspected diagnosis but a negative chest radiograph, or CXR, according to research published in Pediatrics. Researchers noted that most of these children can be monitored without needing treatment with antibiotics.

Nabriva Therapeutics announced positive topline results from a second phase 3 clinical trial of lefamulin for the treatment of community-acquired bacterial pneumonia, showing that the investigational antibiotic met all FDA and European Medicines Agency primary endpoints.

Air pollution causes 7 million deaths worldwide each year — mostly through noncommunicable diseases like lung cancer, stroke and chronic obstructive pulmonary disease but also through acute respiratory infections like pneumonia, experts said.

People older than 60 years who took proton pump inhibitors long-term showed an increased risk for developing pneumonia, according to new research published in the Journal of the American Geriatrics Society.

Thirteen-valent pneumococcal conjugate vaccine is immunogenic among patients with rheumatoid arthritis and Sjögren’s syndrome who have not been treated with disease modifying anti-rheumatic drugs, according to findings published in BMC Rheumatology.

Infants who experience bronchiolitis during respiratory syncytial virus season within their first 6 months of life are more likely to have otitis media, pneumonia and use antibiotics regardless of their mother’s asthma status, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology in Orlando.

In intubated adult ICU patients, the diagnosis of MRSA ventilator-associated pneumonia, or VAP, is based on epidemiologic/microbiologic criteria. The characteristic clinical features of MRSA pneumonia are well-known from decades of clinical experience with MRSA community-acquired pneumonia in patients with influenza. This is the gold standard of diagnosing MRSA pneumonia.